What are the Challenges in Using Nanotechnology for Biologics?
Despite its potential, there are several challenges in using nanotechnology for biologics:
Safety: Ensuring that nanoparticles are biocompatible and do not induce adverse immune responses. Scalability: Producing nanoparticles consistently and in large quantities for clinical use. Regulatory hurdles: Meeting the stringent regulatory requirements for new biologic-nanoparticle therapies. Stability: Ensuring the stability of both the nanoparticles and the biologics they carry during storage and after administration.
